Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · IEX Real-Time Price · USD
29.50
+0.78 (2.72%)
At close: May 17, 2024, 4:00 PM
29.39
-0.11 (-0.37%)
After-hours: May 17, 2024, 7:50 PM EDT
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $2.82 billion as of May 17, 2024. Its market cap has increased by 255.76% in one year.
Market Cap
2.82B
Enterprise Value
1.91B
1-Year Change
255.76%
Ranking
Category
Stock Price
$29.50
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $939.10M to $2.82B, an increase of 200.22%. That is a compound annual growth rate of 32.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 2.82B | 2.72% |
May 16, 2024 | 2.75B | -2.68% |
May 15, 2024 | 2.82B | 2.07% |
May 14, 2024 | 2.76B | 11.11% |
May 13, 2024 | 2.49B | 0.23% |
May 10, 2024 | 2.48B | -4.21% |
May 9, 2024 | 2.59B | 24.76% |
May 8, 2024 | 2.08B | 2.64% |
May 7, 2024 | 2.02B | -3.57% |
May 6, 2024 | 2.10B | -0.46% |
May 3, 2024 | 2.11B | 3.40% |
May 2, 2024 | 2.04B | -0.86% |
May 1, 2024 | 2.06B | 6.92% |
Apr 30, 2024 | 1.92B | -2.31% |
Apr 29, 2024 | 1.97B | 1.40% |
Apr 26, 2024 | 1.94B | 2.23% |
Apr 25, 2024 | 1.90B | -5.02% |
Apr 24, 2024 | 2.00B | -0.19% |
Apr 23, 2024 | 2.00B | 4.06% |
Apr 22, 2024 | 1.93B | 6.29% |
Apr 19, 2024 | 1.81B | -1.34% |
Apr 18, 2024 | 1.84B | -2.17% |
Apr 17, 2024 | 1.88B | -1.51% |
Apr 16, 2024 | 1.91B | - |
Apr 15, 2024 | 1.91B | -0.74% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Denali Therapeutics | 2.97B |
Corcept Therapeutics | 2.90B |
Neogen | 2.88B |
LifeStance Health Group | 2.86B |
Amicus Therapeutics | 2.86B |
Twist Bioscience | 2.82B |
Immunocore Holdings | 2.80B |
MorphoSys AG | 2.79B |